Research on aCLs subtypes (IgM and IgG) in stroke suggests that elevated levels of IgM aCL may increase stroke risk, while IgG aCL does not predict thrombosis recurrence, indicating subtype-specific effects on thrombotic events. This evidence concerns the gene CD40LG and stroke disorder.